Midwest Professional Planners Ltd (MPPL)’s Niagen Bioscience NAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$66.8K Hold
20,950
0.01% 131
2026
Q1
$92.4K Hold
20,950
0.02% 137
2025
Q4
$133K Hold
20,950
0.03% 142
2025
Q3
$195K Hold
20,950
0.05% 148
2025
Q2
$302K Hold
20,950
0.08% 136
2025
Q1
$145K Hold
20,950
0.05% 155
2024
Q4
$111K Hold
20,950
0.03% 152
2024
Q3
$76.5K Hold
20,950
0.02% 153
2024
Q2
$57.2K Hold
20,950
0.02% 146
2024
Q1
$72.9K Hold
20,950
0.03% 146
2023
Q4
$30K Hold
20,950
0.01% 129
2023
Q3
$30.6K Hold
20,950
0.01% 125
2023
Q2
$32.9K Hold
20,950
0.01% 124
2023
Q1
$32.1K Hold
20,950
0.02% 120
2022
Q4
$35.2K Hold
20,950
0.02% 122
2022
Q3
$26K Hold
20,950
0.02% 117
2022
Q2
$35K Hold
20,950
0.02% 114
2022
Q1
$52K Hold
20,950
0.03% 119
2021
Q4
$78K Hold
20,950
0.04% 115
2021
Q3
$131K Hold
20,950
0.07% 114
2021
Q2
$207K Buy
+20,950
New +$183K 0.11% 114
2021
Q1
Sell
-40,950
Closed -$197K 123
2020
Q4
$197K Buy
+40,950
New +$200K 0.12% 111

Other funds holding NAGE

Midwest Professional Planners Ltd (MPPL)'s NAGE Position: Q2 2026 in Review

Midwest Professional Planners Ltd (MPPL) held its Niagen Bioscience (NAGE) position steady in Q2 2026 at 20,950 shares worth $66.8K. The position accounts for 0.01% of the portfolio, ranked #131.

Midwest Professional Planners Ltd (MPPL) first reported a position in NAGE in Q4 2020 and has held it in 22 quarters since. The position peaked at $302K in Q2 2025. 140 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

  • Midwest Professional Planners Ltd (MPPL) held 20,950 shares of Niagen Bioscience worth $66.8K as of Q2 2026.
  • Midwest Professional Planners Ltd (MPPL) left its Niagen Bioscience share count unchanged in Q2 2026.
  • Niagen Bioscience made up 0.01% of Midwest Professional Planners Ltd (MPPL)'s portfolio in Q2 2026, its #131 holding.
  • Midwest Professional Planners Ltd (MPPL) first reported a position in Niagen Bioscience in Q4 2020 and has held it in 22 quarters since.
  • Midwest Professional Planners Ltd (MPPL)'s Niagen Bioscience position peaked at $302K in Q2 2025.
  • 140 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on Midwest Professional Planners Ltd (MPPL)'s 13F filing for Q2 2026, filed 5 Aug 2026.